Results 11 to 20 of about 63,312 (252)

Mesothelioma

Cytojournal, 2022
Mesothelioma arises from the surface serosal cells lining the pleural, peritoneal, and pericardial cavities. It has three variants including: epithelioid, sarcomatous/desmoplastic, and biphasic types. Mesothelioma cells, predominantly of the epithelioid type, can shed into effusions as sheets, clusters/ morulae, papillae, or single cells.
Rao, Nagarjun, Wei, Shuanzeng
openaire   +4 more sources

Mesothelioma [PDF]

Journal of Thoracic Oncology, 2012
Malignant pleural mesothelioma (MPM) is a rare cancer mostly associated with asbestos exposure (reviewed in1) although very recently it has been found that germline mutations in BRCA1 associated protein-1 (BAP1) may predispose to mesothelioma development
Emanuela Felley-Bosco, Felley-Bosco, Emanuela, Isabelle Opitz, Opitz, Isabelle   +3 more
openaire   +3 more sources

Interleukin 32 Expression in Mesothelioma [PDF]

Thoracic Cancer
Background Interleukin 32 (IL32) has context‐dependent roles in carcinogenesis across cancer types. In this study, we examined IL32 in mesotheliomas.
Takuya Mikamo, Riko Niwa, Yuki Hanamatsu, Tamotsu Takeuchi   +3 more
doaj   +2 more sources

The experience of mesothelioma in Northern England [PDF]

, 2007
Mesothelioma is a potentially preventable fatal disease causing almost 2000 deaths/year in the UK, increasing in incidence, and lacking effective treatments.
Clayson, Helen
core   +6 more sources

Mesothelioma [PDF]

Cancers, 2021
Malignant mesothelioma is a disease affecting serosal surfaces derived from the mesothelium comprising the pleura, peritoneum, pericardium, and tunica vaginalis testis [...]
openaire   +2 more sources

Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire

BMJ Open Respiratory Research, 2022
Objectives Malignant mesothelioma is an aggressive malignancy of mesothelial surfaces, most commonly those of the pleura. The aim of this study was to understand, using a national questionnaire, the gendered care experiences of patients with malignant ...
Liz Darlison, Lorraine Creech, Angela Tod, Michaela Senek, Steve Robertson   +4 more
doaj   +1 more source

Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial

EClinicalMedicine, 2022
Summary: Background: Currently, there is no US Food and Drug Administration approved therapy for patients with pleural mesothelioma who have relapsed following platinum-doublet based chemotherapy. Vinorelbine has demonstrated useful clinical activity in
Dean A. Fennell, Catharine Porter, Jason Lester, Sarah Danson, Paul Taylor, Michael Sheaff, Robin M Rudd, Aarti Gaba, Sara Busacca, Lisette Nixon, Georgina Gardner, Liz Darlison, Charlotte Poile, Cathy Richards, Peter-Wells Jordan, Gareth Griffiths, Angela Casbard   +16 more
doaj   +1 more source

The therapeutic implications of the genomic analysis of malignant pleural mesothelioma

Nature Communications, 2021
Delineation of the genomic complexities of malignant pleural mesothelioma (MPM) has lagged behind other malignancies. Zhang et al. meaningfully add to our understanding of MPM, and their findings emphasize the need to combine drug development efforts ...
Marjorie G. Zauderer
doaj   +1 more source

Must countries shoulder the burden of mesothelioma to ban asbestos? A global assessment

BMJ Global Health, 2022
Introduction Mesothelioma is a key asbestos-related disease (ARD) but can be difficult to diagnose. Countries presumably ban asbestos to reduce future ARD burdens, but it is unknown if countries ban asbestos as a consequence of ARD burdens.
Seong-Kyu Kang, Ro-ting Lin, Sonja Klebe, Ken Takahashi, Odgerel Chimed-Ochir, Anna K Nowak, Tatsuhiko Kubo, Sugio Furuya, Emma M Rath, Yui Yumiya, Kim Brislane   +10 more
doaj   +1 more source

Malignant Mesothelioma [PDF]

Cancers, 2021
Malignant mesothelioma (MM) is a rare and aggressive cancer, related to chronic inflammation and oxidative stress caused mainly by exposure to asbestos [...]
Daniel L. Pouliquen, Joanna Kopecka
openaire   +3 more sources